Standing, Stepping and Voluntary Movement Spinal Cord Epidural Stimulation
Task-specific Epidural Stimulation and Training for Recovery of Stepping, Standing and Voluntary Movement Following Severe Spinal Cord Injury
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- non-progressive SCI
- at least 2 years post injury
- stable medical condition
- inability to walk independently overground
- unable to voluntarily move all individual joints of the legs
Exclusion Criteria:
- ventilator dependent
- untreated painful musculoskeletal dysfunction, fracture or pressure sore
- untreated psychiatric disorder or ongoing drug abuse
- cardiovascular, respiratory, bladder, or renal disease unrelated to SCI
- pregnant at the time of enrollment or planning to become pregnant during the time course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Stand, Step and Voluntary Training
|
Participants will have at least 80 sessions of stand and step training with the assistance of trainers over-ground, or in a harness on a body weight supported treadmill.
Participants will be have at least 80 sessions of stand and step training with epidural stimulation, with the assistance of trainers over-ground, or in a harness on a body weight supported treadmill.
Voluntary movement with epidural stimulation will be completed in the supine or seated position.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline of lower extremity independence time during 10 min standing bout after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
We will measure the amount of time individuals are able to stand without manual assistance (independently) throughout a 10 min bout
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline of stepping independence time during 6 min stepping bout after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
We will measure the number of steps individuals are able to take without manual assistance (independently) throughout a 6 min stepping bout
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline of number of consecutive hip flexion repetitions performed within one minute after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
We will measure the ability of the individuals to perform consecutive hip flexion repetitions with stimulation during a 1-minute period
|
Baseline, 160 sessions (1 year)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in resting metabolic rate after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Resting metabolic rate
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in forced vital capacity (FVC) after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Respiratory Motor Control Assessment
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in maximum inspiratory pressure (MIP) after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Respiratory Motor Control Assessment
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in forced expiratory volume in one second (FEV1) after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Respiratory Motor Control Assessment
|
Baseline, 160 sessions (1 year)
|
|
Change in baseline in maximum expiratory pressure (MEP) after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Respiratory Motor Control Assessment (RMCA)
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in bladder capacity after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using urodynamics we will measure bladder capacity in mL.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in bladder voiding efficiency after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using urodynamics we will measure voiding efficiency (leak amount/total capacity)x100.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in detrusor pressures during filling after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using urodynamics we will measure detrusor pressure in cmH2O.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in bladder compliance after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using urodynamics we will measure bladder compliance in mL/cmH2O.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in mean resting anal pressure after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using anorectal manometry we will measure mean resting pressure in mmHg.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in mean squeeze pressure after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using anorectal manometry we will measure mean squeeze pressure in mmHg.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in mean squeeze increase pressure after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using anorectal manometry we will measure mean squeeze increase pressure in mmHg.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in squeeze anal canal length after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using anorectal manometry will measure squeeze anal canal length in cm.
|
Baseline, 160 sessions (1 year)
|
|
Change from baseline in bowel sensation after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
Using anorectal manometry we will measure bowel sensation in mL.
|
Baseline, 160 sessions (1 year)
|
|
Change in baseline in sexual function after 160 sessions (1 year)
Time Frame: Baseline, 160 sessions (1 year)
|
We will measure change in sexual health function using a questionnaire.
|
Baseline, 160 sessions (1 year)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Susan Harkema, PhD, University of Louisville
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 17.1024 MC-PP-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.